Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Rigel Pharmaceuticals (RIGL) Shares Issued (2016 - 2025)

Rigel Pharmaceuticals has reported Shares Issued over the past 16 years, most recently at $2.9 million for Q4 2025.

For Q4 2025, Shares Issued rose 99.86% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $8.1 million, up 312.47%, while the annual FY2025 figure was $8.1 million, 312.47% up from the prior year.
Shares Issued for Q4 2025 was $2.9 million at Rigel Pharmaceuticals, down from $4.3 million in the prior quarter.
Over five years, Shares Issued peaked at $4.3 million in Q3 2025 and troughed at $1000.0 in Q1 2023.
A 5-year average of $948052.6 and a median of $553000.0 in 2023 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: crashed 99.89% in 2023 and later skyrocketed 8800.0% in 2024.
Year by year, Shares Issued stood at $1.1 million in 2021, then plummeted by 46.08% to $585000.0 in 2022, then dropped by 16.92% to $486000.0 in 2023, then skyrocketed by 201.44% to $1.5 million in 2024, then surged by 99.86% to $2.9 million in 2025.
Business Quant data shows Shares Issued for RIGL at $2.9 million in Q4 2025, $4.3 million in Q3 2025, and $418000.0 in Q2 2025.